Top news of the week: 03.06.2022.
Upstream Bio Dives into Severe Asthma Space with $200M in Series A Financing
Upstream Bio is focusing its efforts on an experimental treatment for severe asthma licensed from Astellas Pharma.
Seattle’s Sana Biotech Shifts Manufacturing to Bothell, Washington, Adds Key Leaders
Seattle-based Sana Biotechnology is moving on from its current Fremont, California manufacturing facility, inking a lease deal to develop a manufacturing plant in Bothell, Washington.
Latinx Employees Face Challenges Succeeding in the Life Sciences Industry
BioSpace looks at the challenges faced by the Latinx community in the life sciences, from the origins of the challenges, to educational gain and the importance of mentorship.
Biopharma Companies Team Up to Fight Diabetes, Alzheimer’s and Cancer
Several new biotech and biopharma agreements involving companies are sharing their strengths to develop new treatments for high-need diseases diabetes, Alzheimer’s and cancer.
Evonik to Build $220M Lipid Plant in U.S. for mRNA-Based Therapies
In partnership with the U.S. government, Evonik Industries is investing more than $200 million to build a lipid manufacturing facility in the United States.
Amgen and NSG Biolabs Announce Golden Ticket to Boost Singapore's Biotech Ecosystem
Amgen and NSG Biolabs Announce Golden Ticket to Boost Singapore's Biotech Ecosystem - read this article along with other careers information, tips and advice on BioSpace
Samantha Truex officially unwraps Upstream Bio, her secretive, OrbiMed-backed biotech with $200M in the bank
After Samantha Truex shut down Quench Bio early last year, she knew she wanted to get back into the biotech world and run another company. The path just ended up more winding than initially ...
MassBio Report Highlights Hiring Struggles in the Life Sciences Industry
In a recent Massachusetts Biotechnology Council survey, 94.2% of respondents reported having difficulty hiring experienced workers.